PHARMACY

FDA panel to review potential new use for Xgeva

BY Allison Cerra

THOUSAND OAKS, Calif. — Drug maker Amgen will discuss the supplemental biologics license application of Xgeva before a Food and Drug Administration review panel next month.

Amgen will participate in a meeting of the Oncologic Drugs Advisory Committee on Feb. 8, where the panel will review results from clinical studies in support of Xgeva as a treatment of castration-resistant prostate cancer in men that are at high risk of developing bone metastases, a new indication for the drug. The company said there currently is no approved treatments to delay or prevent the spread of cancer to bone among this specific patient population.

The sBLA was submitted this past June, and a Prescription Drug User Fee Act action date has been scheduled for April 26 of this year. If approved, this will be the second indication of Xgeva in the United States.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Teva leader to exit company in May, former Bristol executive to step in

BY Allison Cerra

JERUSALEM — Teva Pharmaceutical Industries announced that Shlomo Yanai, president and CEO, will retire from his post in May.

Yanai, who has served in this capacity for five years, has helped Teva expand from a mainly generics business to a more diversified pharmaceutical company, with expected 2012 revenue of approximately $22 billion, and an expanded footprint in the European, Asian and Latin America markets.

Yanai will be succeeded by former Bristol-Myers Squibb executive Jeremy Levin. At Bristol, Levin direct responsibility for strategy, alliances and transactions, and managed its portfolio of alliances.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

CVS/pharmacy looks to attract Tricare members with new online service

BY Antoinette Alexander

WOONSOCKET, R.I. — CVS/pharmacy has launched a new service on its CVS.com website to assist military service members, veterans and their families who need to transfer their prescriptions to a pharmacy that lets them continue using their Tricare prescription insurance coverage.

Tricare members will find at CVS.com/tricare all of the information they need to transfer their prescriptions to one of CVS/pharmacy’s 7,300 pharmacies across the United States. To help raise awareness of CVS/pharmacy’s new Web page for Tricare members, the company will donate $3 to the USO for every person who visits the site between Jan. 1 and Jan. 31, up to a total of $50,000.

"CVS/pharmacy is committed to helping Tricare members on their path to better health, which is why we want to make it as easy as possible for members whose insurance may no longer be accepted at their current pharmacy to transfer their prescriptions to us," stated Papatya Tankut, VP professional pharmacy services at CVS/pharmacy. "To help ensure that patients take their medications appropriately and safely, it is important that they have all their prescriptions filled at the same pharmacy. CVS/pharmacy can fill all existing and new prescriptions for Tricare members."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?